Chargement en cours...
Anti-HCV drugs in the pipeline
Several directly-acting and host-targeting antivirals that inhibit hepatitis C virus replication have entered clinical trials. Amongst the most advanced of these are RG7128, an inhibitor of the NS5B polymerase; BMS-790052, an inhibitor of NS5A; and alisporivir, an inhibitor of human cyclophilins. Th...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3775341/ https://ncbi.nlm.nih.gov/pubmed/22440918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coviro.2011.10.019 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|